Weighing the Risks and Benefits of DOACs in Morbidly Obese Patients, With Drs. Damon Houghton & Karlyn Martin
Contributing Editor Dr. Damon Houghton has a conversation with Dr. Karlyn Martin about the updated recommendations from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Subcommittee on Control of Anticoagulation on the use of direct oral anticoagulants in patients with obesity for the treatment and prevention of venous thromboembolism.
In this podcast, Contributing Editor Dr. Damon Houghton has a conversation with Dr. Karlyn Martin. They discuss a Journal of Thrombosis and Haemostasis article covered by Dr. Houghton in his most recent Diffusion article titled, “Weighing the Risk and Benefits of Direct Oral Anticoagulants in Morbidly Obese Patients: New Data and Guidance.” In the article, Dr. Houghton discusses the updated recommendations from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Subcommittee on Control of Anticoagulation on the use of direct oral anticoagulants in patients with obesity for the treatment and prevention of venous thromboembolism. You can access his Diffusion article online at: https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.6.2021610/477245/Weighing-the-Risk-and-Benefits-of-Direct-Oral.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
